Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Binding of select forms of pRB to protein phosphatase type 1 independent of catalytic activity

Abstract

The product of the retinoblastoma susceptibility gene, pRB, is a demonstrated substrate for the type 1 serine/threonine protein phosphatases (PP1). Curiously, there has been a paucity of data supporting the idea that phosphorylated pRB can be found in a complex with PP1. To more fully characterize the association between these two proteins, we utilized a PP1-affinity chromatography approach to increase our ability to capture from mammalian cell lysate populations of pRB capable of binding to PP1. Western blot analysis of the bound proteins indicates that both faster migrating, hypophosphorylated pRB, as well as slower migrating, hyperphosphorylated pRB can bind. Phosphorylated pRB binding was confirmed by immunoprecipitation of eluted 32P-labeled pRB. In addition, Western blotting of eluted proteins with pRB phosphorylated-site-specific antibodies revealed select phosphorylated forms of pRB binding to PP1. Similar binding studies performed with toxin-inhibited PP1 indicate that catalytic activity of PP1 is not required for pRB binding. The significance of this finding with respect to the functional importance of this interaction is discussed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Alberts AS, Thornburn AM, Shenolikar S, Mumby MC and Feramisco JR. . 1993 Proc. Natl. Acad. Sci. USA 90: 388–392.

  • Allen PB, Kwon Y-G, Nairn AC and Greengard P. . 1998 J. Biol. Chem. 273: 4089–4095.

  • Bagu JR, Dykes BD, Craig MM and Holmes CFB. . 1997 J. Biol. Chem. 272: 5087–5097.

  • Bialojan C and Takai A. . 1988 Biochem. J. 256: 283–290.

  • Buchkovich K, Duffy LA and Harlow E. . 1989 Cell 58: 1097–1105.

  • Chen PL, Scully P, Shew JY, Wang JYJ and Lee W-H. . 1989 Cell 58: 1193–1198.

  • Cohen P, Schelling DL and Stark MJ. . 1989 FEBS Lett. 250: 601–606.

  • DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM and Livingston DM. . 1989 Cell 58: 1085–1095.

  • Durfee T, Becherer K, Chen PL, Yeh SH, Yang Y, Kilburn AE, Lee W-H and Elledge SJ. . 1993 Genes Dev. 7: 555–556.

  • Egloff MP, Cohen PTW, Reinemer P and Bardford D. . 1995 J. Mol. Biol. 254: 942–959.

  • Goldberg J, Huang H, Kwon Y, Greengard P, Nairn AC and Kuriyan J. . 1995 Nature 376: 745–753.

  • Hardie DG, Haystead TAJ and Sim ATR. . 1991 Method Enzymol. 201: 469–476.

  • Herwig S and Strauss M. . 1997 Eur. J. Biochem. 246: 581–601.

  • Kaelin WG, Pallas DC, Decaprio JA, Kaye FJ and Livingston DM. . 1991 Cell 64: 521–532.

  • Knudsen ES and Wang JYJ. . 1996 J. Biol. Chem. 271: 8313–8320.

  • Kwon YG, Huang HB, Desdouits JA, Girault JA, Greengard P and Nairn AC. . 1997 Proc. Natl. Acad. Sci. USA 94: 3536–3541.

  • Laemmli UK. . 1970 Nature 227: 680–685.

  • Ludlow JW. . 1996 J. Virol. Methods 59: 105–112.

  • Ludlow JW and Nelson DA. . 1995 Cancer Biol. 6: 195–202.

  • Ludlow JW, Glendening CL, Livingston DM and DeCaprio JA. . 1993 Mol. Cell. Biol. 13: 367–372.

  • Ludlow JW, Shon J, Pipas JM, Livingston DM and DeCaprio JA. . 1990 Cell 60: 387–396.

  • Lundberg AS and Weinberg RA. . 1998 Mol. Cell. Biol. 18: 753–761.

  • Lussow AR, Barrios C, Embden JV, Zee RV, Verdini AS, Pesi A, Louis JA, Lambert P-H and Giudice GD. . 1991 Eur. J. Immunol. 21: 2297–2302.

  • MacKintosh RW, Dalby KN, Campbell DG, Cohen PTW, Cohen P and MacKintosh C. . 1995 FEBS Lett. 371: 236–240.

  • MacKintosh C and MacKintosh RW. . 1994 Trends Biochem. Sci. 19: 944–948.

  • Mihara K, Cao X-R, Yen A, Chandler S, Driscoll B, Murphee AL, T'Ang A and Fung U-KT. . 1989 Science 246: 1300–1303.

  • Mittnacht S, Lees JA, Desai D, Harlow E, Morgan DO and Weinberg RA. . 1994 EMBO J. 13: 118–127.

  • Moorhead G, MacKintosh C, Morris N and Cohen P. . 1995 FEBS Lett. 362: 101–105.

  • Nelson DA and Ludlow JW. . 1997 Oncogene 14: 2407–2415.

  • Nelson DA, Krucher NA and Ludlow JW. . 1997 J. Biol. Chem. 272: 4528–4535.

  • Phelps WC, Munger K, Yee CL, Barnes JA and Howley PM. . 1992 J. Virol. 66: 2418–2427.

  • Riley D, Lee EY-HP and Lee W. . 1995 Annu. Rev. Cell. Biol. 10: 1–29.

  • Shima H, Hatano Y, Chun Y-S, Sugimura T, Zhang Z, Lee EYC and Nago M. . 1993 Biochem. Biophys. Res. Commun. 192: 1289–1296.

  • Siegert JL and Robbins PD. . 1999 Mol. Cell. Biol. 19: 846–854.

  • Takai C, Bialogan M, Troschka M and Ruegg JC. . 1987 FEBS Lett. 217: 81–84.

  • Takemura M, Kitagawa T, Izuta S, Wasa J, Takai A, Akiyama T and Yoshida S. . 1997 Oncogene 15: 2483–2492.

  • Tognarini M and Villa-Moruzzi E. . 1998 In: Ludlow, J.W. (eds). Methods in Molecular Biology Vol 93: Protein Phosphatase Protocols. Humana Press Inc., Totowa, NJ. pp. 169–183.

    Book  Google Scholar 

  • Towbin H, Staehelin T and Gordon J. . 1979 Proc. Natl. Acad. Sci. USA 76: 4350–4354.

  • Weinberg RA. . 1995 Cell 81: 323–330.

  • Zarkowska T and Mittnacht S. . 1997 J. Biol. Chem. 272: 12738–12746.

  • Zhang L, Zhang Z, Long F and Lee EYC. . 1996 Biochemistry 35: 1606–1611.

Download references

Acknowledgements

This work was supported by Research Project Grant # 98 – 108 from the American Cancer Society, The Sally Edelman & Harry Gardner Cancer Research Foundation (awarded to JW Ludlow) and Cancer Center Core Grant CA11198.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tamrakar, S., Mittnacht, S. & Ludlow, J. Binding of select forms of pRB to protein phosphatase type 1 independent of catalytic activity. Oncogene 18, 7803–7809 (1999). https://doi.org/10.1038/sj.onc.1203211

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1203211

Keywords

This article is cited by

Search

Quick links